Blog
-
Global Resources Investment Trust – value realisation horizon nears
The release of GRIT’s final results for the year ended 2016 on Friday 28th April per HERE was largely an academic exercise. Following the restructuring of the company as detailed in the circular of December last year the company is now focused upon the creation of value within its remaining major constituent companies which include Anglo […]
-
Silence Therapeutics – Expansion of Intellectual Property portfolio supports further long-term value
By Richard Gill, CFA The AIM listed RNA therapeutics specialist Silence Therapeutics (SLN) has announced a significant expansion of its chemical modification patent estate. In March this year the company revealed that the European Patent Office had granted a patent covering key RNAi chemical modifications, thus giving it further protection for its technology across many […]